ELAN Stock Analysis: Buy, Sell, or Hold?
ELAN - Elanco Animal Health Incorporated Common Stock
$23.22
0.09 (0.37%)
▲
5d:
-5.01%
30d:
-12.06%
90d:
+2.72%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Distribution
ELAN is up 5.9% this week, but smart money is buying puts. Top strike: $22 2026-03-20 with 6,212 OI. Put ratio: 71% View Scanner →
Strength: 5.1/10
Get Alerted When ELAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ELAN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ELAN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.53
Based on 8.2% avg growth
INTRINSIC VALUE TODAY
$23.93
3.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELAN is currently trading at $23.21, which is considered slightly low relative to its 30-day fair value range of $23.49 to $25.71. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.8) compared to its historical average (22.3). Remarkably, the market is currently pricing in an annual earnings decline of 3.9% over the next few years. This pessimistic expectation contrasts with the company's recent 116.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ELAN is in a strong uptrend. The price is currently testing key support at $22.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ELAN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $28.77 (+24.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELAN is in a strong uptrend. The price is currently testing key support at $22.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ELAN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $28.77 (+24.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$23.49 -
$25.71
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding ELAN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.4% below Wall St target ($28.77)
- CAUTION: 5-day price weakness (-5.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$23.49 -
$25.71
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$22.74
Resistance Level
$25.68
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.77
Wall Street Target
$28.77
(+24.4%)
Revenue Growth (YoY)
12.2%
Earnings Growth (YoY)
116.7%
Profit Margin
-4.9%
Valuation Discount vs History
-3.9% cheaper
PE vs Historical
19.8 vs 22.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.9%
(market-implied from PE analysis)
1-Year Target
$22.23
(-4%)
2-Year Target
$21.36
(-8%)
3-Year Target
$20.53
(-11%)
3-Yr Target (if PE normalizes)
(PE: 20→22)
$23.16
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 12.3%)
$37.07
(+60%)
Base:
(SPY PE: 19.8, Growth: 12.3%)
$32.72
(+41%)
Bear:
(PE: 16.8, Growth: 12.3%)
$27.81
(+20%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.8 to 22.3
Stabilization Target:
$26.09
(+12.8%)
PE Expansion Potential:
+12.8%
Share & Embed Analysis
Last updated: March 30, 2026 1:25 PM ET
Data refreshes hourly during market hours. Next update: 2:25 PM
Data refreshes hourly during market hours. Next update: 2:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAN showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Lawrence Erik Kurzius
BUY
10000 shares
2025-12-12
Jeffrey N Simmons
BUY
22000 shares
2025-12-11
Rajeev A Modi
BUY
4500 shares
2025-12-11
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 55 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 60 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 58 HOLD |
Advanced ELAN Option Strategies
Professional options setups generated by AI based on today's ELAN price and gamma walls.
